Ten Cutting-edge Medical Device and Imaging Technologies to Transform the Healthcare Sector
Solutions incorporating innovations from diverse industries will remain at the heart of medical diagnosis and treatment, finds Frost & Sullivan
MOUNTAIN VIEW, California, Sept. 21, 2015 /PRNewswire/ -- An array of sophisticated inventions in medical devices, diagnostics and imaging have given birth to less expensive and flexible healthcare solutions, playing a critical role in managing the increasing frequency of chronic diseases around the globe. A striking feature of Frost & Sullivan's list of top medical technologies of 2015 is the potential of these technologies to address needs across developed, developing and emerging countries.
Logo - http://photos.prnewswire.com/prnh/20150921/268694LOGO
Analysis from Frost & Sullivan, Top Medical Device and Imaging Technologies in 2015 (https://www.frost.com/d691), reveals growth in the healthcare industry will center around the following 10 technologies: surgical robots, digital pathology, neuroprosthetics, surgical laser, smart pills, optical imaging, health informatics, integrated vital signs monitoring, artificial organs and four-dimensional (4D) ultrasound imaging. New modalities such as neuroprosthesis and hybrid imaging are moving towards commercialization. Technologies already in the early commercialization phase, including smart pills and surgical robots, will find widespread uses across applications.
For complimentary access to more information on this research, please visit: http://bit.ly/1Kg4fzL.
"The strong merits of the top 10 medical device and imaging technologies attract the attention of large and small healthcare companies alike," said Frost & Sullivan TechVision Senior Research Analyst Bhargav Rajan. "Traditionally, cautious tier-1 firms stake claim in these pioneering modalities directly or indirectly through funding, tie-ups and acquisitions."
A common thread connecting the 10 solutions is their scope for convergence with non-medical platforms. Innovations in electronics, sensors, information technology and advanced manufacturing are actively powering product and technology progress in medical and imaging devices. Non-healthcare businesses such as Google and IBM invest in these technologies.
"Stringent regulatory requirements as well as a competitive intellectual property landscape prolong the time-to-market and strain returns on investment," noted Rajan. "Collaborative and multi-cluster advancements in conjunction with non-healthcare industries will significantly reduce development times and lower barriers to market entry."
Once commercialized, these multi-disciplinary medical and imaging devices with long lifespans will consistently influence market potential, research and development, and global adoption over several years.
Top Medical Device and Imaging Technologies in 2015, a part of the TechVision (http://ww2.frost.com/research/technology/medical-devices-imaging) subscription, identifies and profiles 10 technologies expected to shape the medical device and imaging industry. The list includes technologies that are already in the market as well as recently commercialized technologies. This research throws light on technology capability, maturity, global research intensity, adoption over the short and medium terms, and funding activities.
Frost & Sullivan's global TechVision practice is focused on innovation, disruption and convergence that provides a variety of technology based alerts, newsletters and research services as well as growth consulting services. Its premier offering, the TechVision program, identifies and evaluates the most valuable emerging and disruptive technologies enabling products with near-term potential. A unique feature of the TechVision program is an annual selection of 50 technologies that can generate convergence scenarios, possibly disrupt the innovation landscape, and drive transformational growth. View a summary of our TechVision program by clicking on the following link: http://ifrost.frost.com/TechVision_Demo.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.
Our "Growth Partnership" supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.
- The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including research, analysis, strategy, vision, innovation and implementation.
- The Partnership Infrastructure is unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.
For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?
Contact Us: Start the discussion
Subscribe: Newsletter on "the next big thing"
Register: Gain access to visionary innovation
Top Medical Device and Imaging Technologies in 2015
D691
Contact:
Kayla Belcher
Corporate Communications – North America
P: +1-210-247-2450
F: +1-210-348-1003
E: kayla.belcher@frost.com
http://www.frost.com
http://www.frost.com/techvision
Share this article